Replens

06/01/2002 - "Replens, a non-hormonal alternative to oestrogen replacement treatment has been shown to be effective in relieving symptoms related to vaginal atrophy in previous studies. "
06/01/2002 - "The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry."
04/01/1996 - "Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women."
04/01/1996 - "This study shows that Replens applied vaginally three times a week, is a full therapy for all symptoms of vaginal atrophy as well as local estrogen. "
04/01/1996 - "This study was designed to evaluate the efficacy of Replens, a non-hormonal moisturizing vaginal gel, on symptoms of vaginal atrophy in postmenopausal women, in comparison with Dienoestrol (Cilag), an oestrogenic vaginal cream. "

07/13/2010 - "A formulation of PVP-coated AgNPs homogenized in Replens gel acts rapidly to inhibit HIV-1 transmission after 1 min and offers long-lasting protection of the cervical tissue from infection for 48 h, with no evidence of cytotoxicity observed in the explants.Based"
06/01/2011 - "In the context of a multisite HIV prevention trial in Southern African women, we examined the effectiveness of the Ortho All-Flex Diaphragm, lubricant gel (Replens) and condoms compared to condoms alone on the incidence of herpes simplex virus type 2 (HSV-2) infections. "
01/01/2008 - "We evaluated the effectiveness of the Ortho All-Flex Diaphragm, lubricant gel (Replens) and condoms compared to condoms alone on the incidence of chlamydial and gonococcal infections in an open-label randomized controlled trial among women at risk of HIV/STI infections. "

01/01/2020 - "Further studies are needed to determine if Replens can be useful as treatment for preterm birth."
01/01/2020 - "Replens decreased the rate of LPS-induced preterm birth within six hours, from 87.5% to 37.5% (P < .005). "
01/01/2020 - "Replens prevents preterm birth by decreasing type I interferon strengthening the cervical epithelial barrier."
01/01/2020 - "It is unknown if Replens, the vehicle for vaginal progesterone, alters cervical epithelial junctional proteins impacting cervical remodeling and preterm birth. "
01/01/2020 - "Replens prevents preterm birth by decreasing the interferon-induced upregulation of MMP13 and the degradation of the cell adhesion protein E-Cadherin. "

01/01/2012 - "Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial."
01/01/2007 - "To determine if use of intravaginal polycarbophil gel (Replens) for 1 month will: (1) lower vaginal pH; (2) improve signs of bacterial vaginosis (BV). "
01/01/2007 - "The effect of polycarbophil gel (Replens) on bacterial vaginosis: a pilot study."

10/01/2006 - "Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections."